Women in Nutraceuticals announces second seminar in Focus on Science series
The session, titled Funding Opportunities for Women’s Health Research, will be held on Thursday June 27, 2024 at 10am EDT/ 4pm CEST.
Photo © AdobeStock.com/Drazen
Women in Nutraceuticals (WIN; Chandler, AZ) has announced its second of three Focus on Science web seminars designed to increase the number of women-specified clinical studies. The session, titled Funding Opportunities for Women’s Health Research, will be held on Thursday June 27, 2024 at 10am EDT/ 4pm CEST.
WIN explains that the webinar will explore the challenges and advantages of funding women’s health research, Specifically, the webinar will take a look at funding opportunities, discuss the priorities in women’s health research, as well as the potential collaborative solutions across government, industry, and academia to help increase the number of studies in women’s health.
The webinar’s speakers will include:
- LaVerne L. Brown, PhD Director of Resilience and Health Studies Program, NIH Office of Dietary Supplements.
- Susan Hazels Mitmesser, PhDChief Science Officer, Pharmavite
- Abbie E. Smith-Ryan, PhD, CSCS*D, FACSM, FNSCA, FISSN Professor of Exercise Physiology & Nutrition; University of North Carolina Chapel Hill
The first seminar of this series, titled Considerations for recruitment of female participants in clinical studies, is available to WIN members on demand through the member website. To register for the upcoming session, visit: https://zoom.us/webinar/register/WN_EDK84yhQTxm9I-dV3ydShg
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
